arrow
W

Wen-Fei Li

Shandong University
H指数:35
被引数:5,687

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CNG (Collaborative Nasopharyngeal Carcinoma Group) stage: Improved prognostic stratification of nasopharyngeal carcinoma and association with Epstein-Barr virus DNA in the intensity-modulated radiation therapy era

CNG(协作鼻咽癌组)分期:IMRT时代鼻咽癌改善预后分层与EB病毒DNA的关系

2025-07-190
PRE
Tissue-resident microbiota signature in nasopharyngeal carcinoma

鼻咽癌中组织驻留微生物组特征

2025-05-170
OA
The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment
2023-06-0634
PRE
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial
2023-02-0616
OAAI
Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma A Randomized Clinical Trial
2022-08-2376
OA
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial

确定局部区域晚期鼻咽癌的最佳临床试验候选者: 对9468例真实病例的分析以及两项3期多中心随机对照试验的验证

2022-02-0114
PRE
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
LANCET
IF88.5
2021-07-01127
PREAI